- EMA Completes an Arbitration Procedure for Dexrazoxane
- EMA Adopts a Negative Opinion for Anamorelin Hydrochloride
- EMA Adopts a New Indication for Ceritinib
- FDA Grants Approval to Pebrolizumab for Advanced or Metastatic Urothelial Carcinoma
- EMA Launches Public Consultations to Revise Three Scientific Guidelines
- NaviCam for Diagnosing Gastrointestinal Tract Conditions
Leading the Debate on the Advances in Healthcare